Stephanie Harris
Recent publications
-
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Journal article
Wilkie M. et al, (2020), Vaccine, 38, 779 - 789
-
Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.
Journal article
Müller J. et al, (2019), JCI insight, 4
-
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Journal article
Manjaly Thomas Z-R. et al, (2019), PLoS medicine, 16
-
Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.
Journal article
Tanner R. et al, (2019), Scientific reports, 9
-
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
Journal article
O’Shea MK. et al, (2018), Scientific Reports, 8